Submitted by Anonymous (not verified) on 1 July 2025 - 13:32
Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 8, Status: Authorised